We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
+7.79%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$22.4B
AUM Growth
+$2.11B
Cap. Flow
+$775M
Cap. Flow %
3.46%
Top 10 Hldgs %
20.85%
Holding
3,349
New
266
Increased
1,598
Reduced
1,206
Closed
184

Sector Composition

Rank Sector Weight
1 Technology 10.23%
2 Consumer Discretionary 4.98%
3 Financials 4.7%
4 Healthcare 3.82%
5 Communication Services 3.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SFT
3101
DELISTED
Shift Technologies, Inc. Class A Common Stock
SFT
$42K ﹤0.01%
1,230
-225
-15% -$12.3K
SAN icon
3102
Banco Santander
SAN
$211B
$40K ﹤0.01%
12,109
+1,086
+10% +$3.81K
WTI icon
3103
W&T Offshore
WTI
$546M
$40K ﹤0.01%
12,241
+1,573
+15% +$6.06K
AVTX icon
3104
Avalo Therapeutics
AVTX
$1.04B
$39K ﹤0.01%
8
+4
+100% +$24K
SQFT icon
3105
Presidio Property Trust
SQFT
$2.09M
$39K ﹤0.01%
1,005
SUPV
3106
Grupo Supervielle
SUPV
$738M
$39K ﹤0.01%
20,002
DMK
3107
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$39K ﹤0.01%
926
OGI
3108
Organigram Holdings
OGI
$177M
$36K ﹤0.01%
5,200
+256
+5% +$2.17K
XWEL icon
3109
XWELL
XWEL
$8.53M
$34K ﹤0.01%
+853
New +$27K
LOGC
3110
DELISTED
ContextLogic
LOGC
$34K ﹤0.01%
367
-94
-20% -$12.5K
GSAT icon
3111
Globalstar
GSAT
$10.7B
$33K ﹤0.01%
1,901
-446
-19% -$9.78K
DHC
3112
Diversified Healthcare Trust
DHC
$2.03B
$32K ﹤0.01%
10,218
-18,683
-65% -$60.4K
ASRT
3113
DELISTED
Assertio
ASRT
$31K ﹤0.01%
+949
New +$19.5K
JFIN
3114
Jiayin Group
JFIN
$120M
$30K ﹤0.01%
+13,650
New +$46.8K
TGB
3115
Trekor Metals
TGB
$3.08B
$30K ﹤0.01%
+14,660
New +$30.6K
REFR icon
3116
Research Frontiers
REFR
$15.2M
$29K ﹤0.01%
16,832
-4,634
-22% -$9.93K
VHC icon
3117
VirnetX Holding Corp
VHC
$64.8M
$29K ﹤0.01%
566
-63
-10% -$4.37K
ASXC
3118
DELISTED
Asensus Surgical, Inc.
ASXC
$29K ﹤0.01%
25,971
-13,600
-34% -$21K
CFMS
3119
DELISTED
Conformis, Inc. Common Stock
CFMS
$29K ﹤0.01%
1,528
+147
+11% +$3.77K
PTE
3120
DELISTED
PolarityTE, Inc. Common Stock
PTE
$27K ﹤0.01%
1,855
-200
-10% -$2.62K
MMAT
3121
DELISTED
Meta Materials Inc. Common Stock
MMAT
$25K ﹤0.01%
+100
New +$41.2K
DCRNW
3122
DELISTED
Decarbonization Plus Acquisition Corporation II Warrant
DCRNW
$24K ﹤0.01%
+15,500
New +$26.9K
ASAP
3123
DELISTED
Waitr Holdings Inc. Common Stock
ASAP
$22K ﹤0.01%
1,507
-975
-39% -$22.7K
HELP
3124
Cybin Inc
HELP
$710M
$20K ﹤0.01%
+441
New +$27.9K
NGD
3125
DELISTED
New Gold Inc
NGD
$20K ﹤0.01%
13,569
-750
-5% -$1.08K

Similar funds

Cambridge Investment Research Advisors's Q4 2021 Portfolio in Review

As of Q4 2021, Cambridge Investment Research Advisors held 3,349 positions worth $22.4B, up 10% from $20.3B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Cambridge Investment Research Advisors deployed $775M of net new capital in Q4 2021, opening 266 new positions and adding to 1,598 existing holdings. Its largest new stake was CION Investment: 424,367 shares worth $5.55M.

By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 9.6% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $19.5M trimmed.

  • Cambridge Investment Research Advisors's largest Q4 2021 buy was CION Investment: 424,367 shares worth $5.55M.
  • Cambridge Investment Research Advisors added most to Invesco QQQ Trust in Q4 2021, an estimated $88.6M increase.
  • Cambridge Investment Research Advisors's biggest Q4 2021 reduction was iShares Russell 2000 ETF, cutting an estimated $19.5M.
  • Cambridge Investment Research Advisors fully exited VEREIT, Inc. in Q4 2021, selling an estimated $5.14M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 21% of its $22.4B portfolio in Q4 2021.
  • Cambridge Investment Research Advisors opened 266 new positions and closed 184 in Q4 2021.
  • Cambridge Investment Research Advisors's portfolio value rose 10% quarter-over-quarter to $22.4B.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2021, filed 3 Feb 2022.